268 related articles for article (PubMed ID: 30903310)
1. The absence of fundus abnormalities in Stargardt disease.
Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
[TBL] [Abstract][Full Text] [Related]
2. Early-onset stargardt disease: phenotypic and genotypic characteristics.
Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
[TBL] [Abstract][Full Text] [Related]
3. Foveal sparing in Stargardt disease.
van Huet RA; Bax NM; Westeneng-Van Haaften SC; Muhamad M; Zonneveld-Vrieling MN; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7467-78. PubMed ID: 25324290
[TBL] [Abstract][Full Text] [Related]
4. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric Inter-Eye Progression in Stargardt Disease.
Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characteristics of late-onset Stargardt's disease.
Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
[TBL] [Abstract][Full Text] [Related]
7. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM;
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696
[TBL] [Abstract][Full Text] [Related]
8. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
Sisk RA; Leng T
Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
[TBL] [Abstract][Full Text] [Related]
9. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.
Chen Y; Ratnam K; Sundquist SM; Lujan B; Ayyagari R; Gudiseva VH; Roorda A; Duncan JL
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3281-92. PubMed ID: 21296825
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characteristics of childhood-onset Stargardt disease.
Fujinami K; Zernant J; Chana RK; Wright GA; Tsunoda K; Ozawa Y; Tsubota K; Robson AG; Holder GE; Allikmets R; Michaelides M; Moore AT
Ophthalmology; 2015 Feb; 122(2):326-34. PubMed ID: 25312043
[TBL] [Abstract][Full Text] [Related]
11. The Rapid-Onset Chorioretinopathy Phenotype of ABCA4 Disease.
Tanaka K; Lee W; Zernant J; Schuerch K; Ciccone L; Tsang SH; Sparrow JR; Allikmets R
Ophthalmology; 2018 Jan; 125(1):89-99. PubMed ID: 28947085
[TBL] [Abstract][Full Text] [Related]
12. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
[TBL] [Abstract][Full Text] [Related]
13. Early Patterns of Macular Degeneration in ABCA4-Associated Retinopathy.
Khan KN; Kasilian M; Mahroo OAR; Tanna P; Kalitzeos A; Robson AG; Tsunoda K; Iwata T; Moore AT; Fujinami K; Michaelides M
Ophthalmology; 2018 May; 125(5):735-746. PubMed ID: 29310964
[TBL] [Abstract][Full Text] [Related]
14. Prognostication in Stargardt Disease Using Fundus Autofluorescence: Improving Patient Care.
Daich Varela M; Laich Y; Hashem SA; Mahroo OA; Webster AR; Michaelides M
Ophthalmology; 2023 Nov; 130(11):1182-1190. PubMed ID: 37331482
[TBL] [Abstract][Full Text] [Related]
15. Deep Scleral Exposure: A Degenerative Outcome of End-Stage Stargardt Disease.
Lee W; Zernant J; Nagasaki T; Tsang SH; Allikmets R
Am J Ophthalmol; 2018 Nov; 195():16-25. PubMed ID: 30055151
[TBL] [Abstract][Full Text] [Related]
16. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
[TBL] [Abstract][Full Text] [Related]
17. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).
Burke TR; Rhee DW; Smith RT; Tsang SH; Allikmets R; Chang S; Lazow MA; Hood DC; Greenstein VC
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8006-15. PubMed ID: 21873672
[TBL] [Abstract][Full Text] [Related]
18. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.
Abalem MF; Otte B; Andrews C; Joltikov KA; Branham K; Fahim AT; Schlegel D; Qian CX; Heckenlively JR; Jayasundera T
Am J Ophthalmol; 2017 Dec; 184():181-188. PubMed ID: 29038010
[TBL] [Abstract][Full Text] [Related]
19. Disruption in Bruch membrane in patients with Stargardt disease.
Park SP; Chang S; Allikmets R; Smith RT; Burke TR; Gregory-Roberts E; Tsang SH
Ophthalmic Genet; 2012 Mar; 33(1):49-52. PubMed ID: 22060670
[TBL] [Abstract][Full Text] [Related]
20. The external limiting membrane in early-onset Stargardt disease.
Lee W; Nõupuu K; Oll M; Duncker T; Burke T; Zernant J; Bearelly S; Tsang SH; Sparrow JR; Allikmets R
Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6139-49. PubMed ID: 25139735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
